SAN DIEGO, Dec. 2, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Vascular Solutions, Inc. (NASDAQ: VASC) breached their fiduciary duties in connection with the proposed sale of the Company to Teleflex Incorporated. Vascular is a medical device company that provides clinical solutions for treating coronary and peripheral vascular disease worldwide.
On December 2, 2016, Vascular announced it had signed a definitive merger agreement with Teleflex. Under the terms of the agreement, Teleflex will acquire all of the outstanding shares of Vascular common stock for $56.00 per share in cash.
The investigation concerns whether the Vascular board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Vascular shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration. A price target of $58.00 was initiated by at least one analyst covering the stock.
If you are a shareholder of Vascular and believe the proposed buyout price is too low and you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (email@example.com) at 619-814-4471.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vascular-vasc-alert-johnson--weaver-llp-launches-an-investigation-into-the-fairness-of-price-and-process-in-proposed-sale-of-vascular-solutions-inc-is-5600-a-fair-price-300372093.html
SOURCE Johnson & Weaver, LLP